Goldrosen M H, Dent P B
Br J Cancer. 1975 Dec;32(6):667-77. doi: 10.1038/bjc.1975.277.
The study of blocking factors requires in vitro assay of cell mediated immunity that parallels the in vivo response. By microcytotoxicity testing, progressor and immune peripheral blood lymphocytes caused significant target cell reduction. The cytotoxicity was specific as no cytotoxic effect was detected against unrelated normal as well as a malignant target cell lines. No anti-tumour effect was noted when progressor peripheral blood lymphocytes were evaluated in the Winn assay. In marked contrast, immune peripheral blood lymphocytes were capable of preventing tumour growth in the Winn assay. Furthermore, hamsters repeatedly immunized with irradiated SV40 tumour cells could resist a live cell challenge. Thus immune peripheral blood lymphocytes were chosen as the effector population to evaluate the abrogation ability of serum in the microcytotoxicity assay.
对阻断因子的研究需要进行与体内反应相似的细胞介导免疫的体外测定。通过微细胞毒性测试,进展期和免疫外周血淋巴细胞导致显著的靶细胞减少。这种细胞毒性具有特异性,因为未检测到对无关正常细胞以及恶性靶细胞系的细胞毒性作用。在Winn试验中评估进展期外周血淋巴细胞时未观察到抗肿瘤作用。与之形成鲜明对比的是,免疫外周血淋巴细胞在Winn试验中能够阻止肿瘤生长。此外,用经辐照的SV40肿瘤细胞反复免疫的仓鼠能够抵抗活细胞攻击。因此,选择免疫外周血淋巴细胞作为效应细胞群体,以评估血清在微细胞毒性试验中的消除能力。